While the effect of the COVID-19 virus on financial markets has been apparent for weeks—US equities fell 30% from February 21 to March 20—we are still months away from realizing the full economic effect. However, the recent Survey of Business Uncertainty (SBU)[1] portends a sharp drop in business activity in 2020. Moreover, business pessimism grew from March 9 to March 20, while the survey was in the field.

When asked directly about the impact of coronavirus developments in mid March, firms see a 6.5 percent negative hit to their sales revenues in 2020. Comparing what firms say about their overall sales outlook in March to what they said in February yields a very similar drop in expected sales revenue. Further, firms’ uncertainty about their own sales growth over the next year rose 44 percent from February to March.

[1]In partnership with Steven Davis of the University of Chicago Booth School of Business and Nicholas Bloom of Stanford University, the Federal Reserve Bank of Atlanta has created the Atlanta Fed/Chicago Booth/Stanford Survey of Business Uncertainty (SBU). This innovative panel survey measures the one-year-ahead expectations and uncertainties that firms have about their own employment, capital investment, and sales. The sample covers all regions of the U.S. economy, every industry sector except agriculture and government, and a broad range of firm sizes.

More on this topic

BFI Data Studio·May 14, 2024

Return to Office and the Tenure Distribution

Austin Wright, David Van Dijcke, and Florian Gunsilius
Return-to-office (RTO) mandates drive employees away from firms, with senior employees leaving at the highest rates, likely leading to significant human capital costs in terms of output, productivity, innovation, and competitiveness for the companies implementing strict RTO policies.
Topics: COVID-19, Employment & Wages
Research Briefs·Mar 7, 2024

What Drives Inflation? Lessons from Disaggregated Price Data

Elisa Rubbo
US inflation in the early phases of the COVID pandemic was entirely driven by disruptions in supply and demand across industries, whereas most of the subsequent increase in consumer prices is driven by aggregate demand.
Topics: COVID-19, Monetary Policy
Research Briefs·Feb 1, 2024

Quantifying the Social Value of a Universal COVID-19 Vaccine and Incentivizing Its Development

Rachel Glennerster, Thomas Kelly, Claire T. McMahon, and Christopher M. Snyder
A universal COVID-19 vaccine that is effective against existing and future variants could provide the United States population with $1.5–$2.6 trillion more in social value than variant-specific boosters. The social value of a universal vaccine eclipses the cost of incentivizing...
Topics: COVID-19